Study shows decline in post-surgery opioid prescriptions, but urges continued efforts

‍Before joining MagicMed Industries, Dr. Jillian Hagel previously held COO and Vice President roles in the biotechnology industry. She focuses on science team coordination and

General Overview A CaaMTech & ASRI Collaboration GH Research & Beckley Psytech: An Update CaaMTech Grows Tryptamine Patent Portfolio Atai Sees Two New Allowances to

Imminent Need for Funding Addressed: Clearmind Medicine Inc.’s announcement of successful capital raising closely aligns with TDR’s earlier analysis, which identified the company’s urgent need